drugset / Trial / NCT00151814
Olmesartan Pediatric Pharmacokinetic (PK) Study
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Determine single dose pharmacokinetic parameters of olmesartan in pediatric patients with hypertension in ages 12 months - 16 years
Timeline
- Start
- 2005-09
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olmesartan medoxomil | Unknown | 0.3 mg/kg | Oral |
| Subject | Olmesartan medoxomil | Unknown | 20 mg | Oral |
| Subject | Olmesartan medoxomil | Unknown | 40 mg | Oral |